DocSym
β
Searchsearch
Search
(Y51.5) Predominantly beta-adrenoreceptor agonists, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis predominantly beta-adrenoreceptor agonists, not elsewhere classified confirmed
507 deaths with diagnosis predominantly beta-adrenoreceptor agonists, not elsewhere classified
3% mortality rate associated with the disease predominantly beta-adrenoreceptor agonists, not elsewhere classified
Diagnosis predominantly beta-adrenoreceptor agonists, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis predominantly beta-adrenoreceptor agonists, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis predominantly beta-adrenoreceptor agonists, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease predominantly beta-adrenoreceptor agonists, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features predominantly beta-adrenoreceptor agonists, not elsewhere classified
Absence or low individual and public risk
Predominantly beta-adrenoreceptor agonists, not elsewhere classified - what does this mean
Predominantly beta-adrenoreceptor agonists, not elsewhere classified is a condition in which the body produces too much of a certain type of hormone called a beta-adrenoreceptor agonist. this hormone binds to beta-adrenoreceptors in the body, resulting in an increased heart rate, increased blood pressure, and other effects. this condition can be caused by a variety of factors, including genetic predisposition, certain medications, and environmental factors.
What happens during the disease - predominantly beta-adrenoreceptor agonists, not elsewhere classified
More details coming soon
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Predominantly beta-adrenoreceptor agonists, not elsewhere classified - Prevention
The prevention of predominantly beta-adrenoreceptor agonists, not elsewhere classified, is primarily achieved through lifestyle changes, such as maintaining a healthy diet, exercising regularly, and avoiding tobacco and alcohol. additionally, it is important to stay informed and up-to-date on any new developments in the field of medicine, and to consult a medical professional when necessary.